CymaBay Therapeutics Inc CBAY

million1000000

Analysis of the CBAY instrument and the possibility of its future movement relative to price ranges.

josiahb1012 Pro+

Looking for price to reject key level and and start to reject trendline and start making new higher higher and contiue to the upside.

CountryKidMoonShot

Given double digit targets across the board, are we headed back up?

Hosselo Premium

❌ - The volume is low on daily but increasing on 4h ✅ - We got double bottom on daily ✅ - We got Bullish engulfing action few days back on the lower channel at $5.64 ✅ - MACD ✅ - STOCH ✅ - DeMarker ❌ - MA50 (13% under 50MA) ✅ - MA200 (6% above 200MA) ❌ - Pivots: (7% under the pivot point) ✅ - Ratings (7) buy ⏰ - Breakout 1: $6, Breakout 2: $6.40 🚀 - Potential...

AlenCiken

CymaBay Announces Positive Topline Results from ENHANCE for Seladelpar in Patients with Primary Biliary Cholangitis -The study demonstrated seladelpar to be efficacious, safe and well-tolerated 78.2% of patients on seladelpar 10 mg versus 12.5% on placebo achieved the primary composite outcome after only 3 months (p<0.0001) - 27.3% of patients on seladelpar...

tickeron

This indicator may be signaling that CBAY's price has momentum to move higher, since its current price exceeds the price logged 14 days ago. Traders may consider buying the stock or exploring call options. I backtested 91 similar cases where CBAY's Momentum Indicator exceeded 0, and 78 of them led to a successful outcome. Odds of Success: 86%.

Bixley Pro

Island..

PennyStock101 Premium

Average analysts price target $2.31 11.3% short interest CymaBay Therapeutics, Inc. is a clinical stage biopharmaceutical company, focused on developing and providing access to therapies for patients with liver and other chronic diseases with high unmet medical need. Its products include MBX-8025 and Arhalofenate, MBX-8025 aims to treat lipid and liver diseases...

Predemption

This baby will pay back to $5 some day in the near future. Buying stock and options. Just thank me later when it eventually doesn

ValuEngine

Expected Returns 1-Month 5.47 1.70% 3-Month 5.54 2.94% 6-Month 5.57 3.62% 1-Year 6.49. 20.59%

Cekaj

Rectangle top in CBAY. High probability of this being a distribution phase.

TelchineCapital

Good price action on upwards trend; current condition is not oversold and poised to continue trend upwards. Trade responsibly; TPs and SLs

Rotuma

Looking for an entry to go long? follow my support and resistance calculation market on the chart

RocketTickers

CBAY: cymabay therapeutics 2018-04-11 07:46:48 Detected possible positive results in drug trial

Brotank77

CBAY looks like it is bound for a break out. It has formed a wedge pattern and has tested the resistance line 6 times since August. The target price is $14.50 while the present price is $9.90. This offers a potential 46% reward. Now as it has just reached a resistance line, a break above this line will be considered bullish and hopefully drive this stock up.

LuchoTrader76 Premium

The chart is beautiful

Evan_Moe_Money

As we see in the H4 timeframe, price was forming a cup, and right now is forming the handle. Since the price already came back from the support, we have good chances it will reach the top of that channel. If we are lucky, it will even break the resistance, and perform a good breakout to the top. We have had higher highs, and higher lows and even the EMA 200 is...

stocknique

above $4.40